Navigation Links
Dilon Technologies Leads Molecular Breast Imaging Expansion

- Clinicians Embrace MBI Technique Breast-Specific Gamma Imaging (BSGI) Resulting in Record 2008 Sales

NEWPORT NEWS, Va., Feb. 10 /PRNewswire/ -- Dilon Technologies, Inc., a leader in molecular breast imaging, today announced record sales for 2008 highlighted by the strongest fourth quarter in the company's history. The company achieved a 35 percent increase in sales from 2007 to 2008 as molecular breast imaging gains nationwide exposure and acceptance.

Breast-Specific Gamma Imaging (BSGI) - a molecular imaging procedure, along with breast MRI, are expected to increase at a compound growth rate of 28 percent over the next five years, according to the Millennium Research Group's U.S. Markets for Women's Health Imaging Systems report. It also states that Dilon Technologies is leading the way to global availability of molecular breast imaging. Dilon's cornerstone product, the Dilon 6800 Gamma Camera is a high-resolution, compact gamma camera optimized to perform BSGI.

"We had a particularly strong finish to the year, breaking through a monthly sales record in December," said Bob Moussa, President and CEO of Dilon Technologies. "Breast imaging centers across the country and around the world are using BSGI to pave the way to effective diagnosis of breast cancer."

BSGI is an adjunctive molecular breast imaging technique to mammography that can see lesions independent of tissue density and discover early stage cancers. With BSGI, the patient receives a pharmaceutical tracing agent that is absorbed by all the cells in the body. Due to their increased rate of metabolic activity, cancerous cells in the breast absorb a greater amount of the tracing agent than normal, healthy cells and generally appear as "hot spots" on the BSGI image.

Dilon's molecular imaging technology is already available in Europe, parts of the Asian-Pacific basin, the Caribbean, and soon to be in Latin America. In addition, Dilon continues to pursue new alliances with companies such as Terason (Terason t3000(TM) Ultrasound System) and PenRad (PenRad Mammography Information System) to help deliver advanced diagnostic solutions to doctors and patients.

"BSGI and our expanded product and service offerings provide critical diagnostic information for physicians to diagnose and treat patients," said Moussa. "More than 50,000 patients have been imaged with BSGI. As we move forward into 2009, we will continue the momentum with the help of physicians worldwide."

About Dilon Technologies

Dilon Technologies, Inc. is bringing innovative new medical imaging products to market. Dilon's cornerstone product, the Dilon 6800, is a high-resolution, small field-of-view gamma camera, optimized to perform BSGI, a molecular breast imaging procedure which images the metabolic activity of breast lesions through radiotracer uptake. Many leading medical centers around the country are now offering BSGI to their patients, including: Cornell University Medical Center, New York; George Washington University Medical Center, Washington, D.C.; and The Rose, Houston. For more information on Dilon Technologies please visit

SOURCE Dilon Technologies, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Dilon Technologies Slant15(TM) and LEHR Collimators Enhance Imaging Capabilities
2. Dilon Technologies Signs Amerinet for Breast-Specific Gamma Imaging
3. Dilon Technologies Announces National Agreement with MedAssets
4. Settlement Reached Between Dilon Technologies and Naviscan on Patent Rights
5. Dilon Technologies Appoints New VP of Sales & Business Development
6. Dilon Technologies Explores Improvements in Molecular Breast Imaging
7. China Medical Technologies to Announce Financial Results for the Third Fiscal Quarter Ended December 31, 2008 on March 2, 2009
8. VNUS Medical Technologies to Present at the Roth 21st Annual OC Growth Stock Conference
9. Greenway Medical Technologies and Navicure Form Partnership to Streamline Claims Management Process
10. ReBuilder Medical Technologies, Inc. to Change Name to American Med Tech
11. Advanced Wound Technologies Mid-Atlantic, Inc. Announces Name Change and Reverse Stock Split
Post Your Comments:
(Date:11/25/2015)... ... 25, 2015 , ... In an ongoing Clinical Study conducted by an independent ... UV Angel is evaluating the efficacy of its product and its disinfection protocol. This ... beds) from May 2014 through October 2015 at a 360-bed, acute-care, academic medical center ...
(Date:11/25/2015)... ... November 25, 2015 , ... In honor of Pulmonary ... individuals and groups responsible for advancing care for pulmonary hypertension (PH) patients and ... the public, will receive special recognition throughout 2016 as part of PHA’s 25th ...
(Date:11/25/2015)... ... ... Many people know of the common symptoms of low thyroid hormone (also known ... people who find their cholesterol levels and weight are creeping up are more likely ... don’t have any of the other symptoms. , Thyroid hormone plays a major role ...
(Date:11/25/2015)... ... November 25, 2015 , ... Bunion ... in an early celebration of the early holiday shopping season. Starting Wednesday November ... (normally $33.95 ea). Black Friday promotional pricing is in addition to any automatic ...
(Date:11/24/2015)... ... November 24, 2015 , ... New patients who wish to seek ... dental implants at her Mississauga, ON practice. Dr. Williams has been providing ... of dental implants. , Missing teeth can lead to a variety of complications ...
Breaking Medicine News(10 mins):
(Date:11/25/2015)... 2015 Kitov Pharma ceuticals ... a biopharmaceutical company focused on the development of therapeutic ... today announced the closing of its previously announced underwritten ... ), each representing 20 ordinary shares of the Company, ... ADSs and warrants were issued in a fixed combination ...
(Date:11/25/2015)... Endo International plc (NASDAQ: ENDP ) (TSX: ... and CEO, will discuss corporate updates at the 27 th ... York on Wednesday, December 2, 2015 at 1 ... Relations, and then the link to the event. Participants should ... to visit the site and download any streaming media software ...
(Date:11/25/2015)... -- Developmental, commercial, and regulatory/legal strategies ... pharmaceutical products, says GBI Research . ... all play a key role in boosting the profitability ... . --> Developmental, commercial, and ... the profitability of pharmaceutical products, says GBI Research ...
Breaking Medicine Technology: